Ichibanya (7630) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
15 May, 2026Executive summary
Net sales for the six months ended August 31, 2025, rose 8.2% year-over-year to ¥32,018 million, with operating profit up 5.5% to ¥2,526 million and ordinary profit up 8.9% to ¥2,708 million.
Profit attributable to owners of parent declined 11.0% year-over-year to ¥1,384 million, and comprehensive income dropped 43.3% to ¥1,198 million.
Basic earnings per share for the period was ¥8.68, down from ¥9.75 in the prior year.
Financial highlights
Gross profit increased to ¥15,963 million from ¥14,677 million year-over-year, while selling, general and administrative expenses rose to ¥13,436 million.
Extraordinary losses increased significantly, mainly due to higher impairment losses and loss on retirement of non-current assets.
Total assets as of August 31, 2025, were ¥47,477 million, up from ¥46,585 million at the previous fiscal year-end.
Net assets stood at ¥32,554 million, with an equity-to-asset ratio of 67.5%.
Outlook and guidance
Full-year forecast for fiscal year ending February 28, 2026, projects net sales of ¥67,300 million (up 10.3% year-over-year), operating profit of ¥5,400 million (up 9.6%), and profit attributable to owners of parent of ¥3,300 million (up 4.0%).
No revisions to previously announced earnings or dividend forecasts.
Latest events from Ichibanya
- Sales up 10.5% year-over-year, but operating profit and net income declined.7630
Q1 202515 May 2026 - Net sales and profit attributable to owners both increased year-over-year, with strong full-year guidance.7630
Q2 202515 May 2026 - Net sales rose 9.3% and profit attributable to owners increased 6.9% year-over-year.7630
Q3 202515 May 2026 - Net sales and profits rose, with strong FY2026 growth guidance and a recent 5-for-1 stock split.7630
Q4 202515 May 2026 - Strong quarterly growth in sales and profits, with positive full-year outlook and stable dividends.7630
Q1 202615 May 2026 - Sales rose 7.7% year-over-year, but profit declined on higher costs; outlook remains positive.7630
Q3 202615 May 2026 - Sales rose 7.4% but net profit dropped 19.2% amid higher costs; 2027 outlook is positive.7630
Q4 202615 May 2026